Oscar Health Inc. (OSCR) Tops Q4 EPS by 12c

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.95), $0.12 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $496.07 million, versus $157.67 million reported last year.

• Direct and assumed premiums of $3,437 million, a 50% increase YoY
• Premiums earned of $1,831 million, a 302% increase YoY
• Net loss of $571 million, an increase of $165 million YoY; Adjusted EBITDA loss of $430 million, an increase of $27 million YoY

GUIDANCE:

Reaffirming 2022 outlook, including direct and assumed policy premiums of $6.1 - $6.4 billion, which would represent a more than 80% YoY increase, at the midpoint

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
• Cerebras Q1 EPS miss sends shares down 9% after-hours